Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Pfizer

New COVID-19 vaccines hit pharmacy shelves

Two new COVID-19 vaccines targeting the new Omicron variant of the virus are now available in Australian pharmacies around the nation.

AAP · Dec 10, 2023

Competition cop Lina Khan’s antitrust overreach is hurting U.S. competitiveness–and destroying billions of dollars in value

Antitrust overreach is hurting America's global competitiveness, with the FTC calculating industry concentration on a purely domestic basis.

Fortune · Dec 7, 2023

How to Buy PFE For a 7% Discount, or Achieve a 16% Annual Return

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Barchart · Dec 5, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

‘It wouldn’t exist’: Viagra inventor tells how Welsh miners began its rise

Dr David Brown says erectile dysfunction drug, subject of a BBC drama, could have been scrapped if a miner hadn’t spoken out

The Guardian - UK · Dec 2, 2023

Stocks Mixed Ahead of Fed Chair Powell

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.10%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.50%. Stocks this morning are mixed, with the Dow Jones...

Barchart · Dec 1, 2023

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK · Dec 1, 2023

Texas lawsuit claims Pfizer exaggerated effectiveness of Covid vaccine

State attorney general Ken Paxton files suit despite medical consensus that vaccine prevents severe infection and death

The Guardian - US · Dec 1, 2023

Read news from The Economist, FT, and more,
with one subscription

Texas attorney general sues Pfizer, claiming vaccines didn’t end pandemic quickly enough

Experts argue other assertions made in the lawsuit filing are completely unsubstantiated, such as one claiming that vaccinated people were more likely to die from COVID-19, which Texas health data disputes.

The Texas Tribune · Nov 30, 2023

1 Pharma Stock to Buy on Strong Vaccine Growth Potential

Unlike many of its peers, GSK just reported a big year-over-year jump in vaccine sales - and there's more growth to come, as the pharmaceutical company expands both its pipeline and the geographical reach for its vaccines.

Barchart · Nov 28, 2023

COVID-19 Booster Shot: Study Says Half Dose Of Pfizer Vaccine Produces Strong Immune Response

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Medical Daily · Nov 27, 2023

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK · Nov 24, 2023

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

The Conversation · Nov 20, 2023

Travis Kelce took a playful swipe at Aaron Rodgers in his interview with The Wall Street Journal

Rodgers isn't coming back from that one.

USA Today Sports Media Group · Nov 20, 2023

Exploring side effects

Most meds have side effects, some subtle, some difficult to handle. However, some drugs have positive side effects, like finasteride for hair growth and sildenafil for impotence. Side effects can be monitored and, with shrewdness, can be used to benefit mankind. Be on the lookout for positive effects when taking…

The Hindu · Nov 18, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart · Nov 17, 2023

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

StockNews.com · Nov 8, 2023

Can Pfizer (PFE) and AbbVie (ABBV) Cure Your Portfolio's Ailments?

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Amid this, let’s analyze the fundamentals of AbbVie (ABBV) and Pfizer (PFE) to determine whether these stocks are worth buying now.

The Independent UK · Nov 7, 2023

Syphilis cases in US newborns skyrocketed in 2022. Health officials suggest more testing

Syphilis cases in U.S. newborns again are on the rise

The Independent UK · Oct 27, 2023

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune · Oct 25, 2023

On 2023’s 100 Fastest-Growing Companies list, Tesla makes its debut and energy companies take off

Tesla was one of several industrial companies in the top five, while Pfizer and energy giants Chevron and ExxonMobil also put up big numbers.

The Hindu · Oct 23, 2023

Pfizer and KIMS Hospital launch Center of Excellence for adult vaccination

Pfizer & KIMS Hospital in Hyderabad inaugurated a CoE for Adult Vaccination to equip HCPs & educate patients on enduring advantages of vaccinations. It will reinforce immunisation against Pneumococcal, Hepatitis A/B, HPV & Influenza. CoE symbolises commitment to protecting individuals against respiratory threats & enhancing quality of life.

The Independent UK · Oct 21, 2023

Company bosses and workers grapple with the fallout of speaking up about the Israel-Hamas war

The fallout from the Israel-Hamas war has spilled into workplaces everywhere, with corporate leaders from the highest ranks of prominent companies weighing in with their views while workers complain their voices are not being heard

Salon · Oct 19, 2023

Pfizer doubling cost of Paxlovid

One of the most effective treatments for COVID is going to get a lot more expensive, but Pfizer insists it's fine

Barchart · Oct 18, 2023

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

The Conversation · Oct 18, 2023

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Independent UK · Oct 16, 2023

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products

Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products

1 … 21 22 23 24

Coverage From

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.